GlassScriptPhysician profile
Kristen Miranda
NPI 1659727378
$7,543.95
in general payments reported to CMS, 2019-2025
27 companies · $1,855 in 2025
The $1,855 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $748 · 2022: $1,232 · 2023: $2,651 · 2024: $1,058 · 2025: $1,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,886 · Travel and Lodging: $1,225 · Consulting Fee: $400 · Education: $51.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,886.46 |
| Travel and Lodging | $1,225.49 |
| Consulting Fee | $400.00 |
| Education | $51.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $2,393.00 | 2022-2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Glaxosmithkline, LLC. | $1,187.55 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,036.74 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Insmed, INC. | $704.20 | 2021-2025 | Arikayce, Brinsupri |
| Bayer Healthcare Pharmaceuticals INC. | $400.00 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.48 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $193.02 | 2022-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $182.61 | 2022-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $165.05 | 2021-2022 | |
| Pfizer INC. | $151.67 | 2021-2025 | |
| Grifols USA, LLC | $130.74 | 2022-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $112.40 | 2023-2025 | Glassia |
| Olympus America INC. | $85.57 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $71.89 | 2022-2023 | Uptravi, Opsumit |
| Verona Pharma, INC. | $68.63 | 2025 | Ohtuvayre |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $63.40 | 2024-2025 | Smartvest |
| Mylan Specialty L.P. | $59.97 | 2021-2024 | Yupelri |
| Philips North America LLC | $45.31 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mallinckrodt Hospital Products INC. | $30.35 | 2023 | Acthar |
| Genzyme Corporation | $26.79 | 2025 | |
| Tactile Systems Technology INC | $25.32 | 2025 | Flexitouch Plus, Nimbl |
| Baxter Healthcare | $22.19 | 2024 | Hillrom - Monarch Airway Clearance System |
| Genentech USA, INC. | $17.93 | 2021 | |
| Harmony Biosciences LLC | $16.90 | 2022 | |
| Jazz Pharmaceuticals INC. | $16.90 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.38 | 2023 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $15.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Miranda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.